 <h1>Ultane Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>sevoflurane</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about sevoflurane. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ultane.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> tachycardia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sevoflurane: inhalation liquid</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sevoflurane (the active ingredient contained in Ultane) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. While you are receiving and recovering from an inhalation anesthetic like sevoflurane, your health care professional will closely follow its effects. However, some effects may not be noticed until later.</p><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sevoflurane may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Cough</li>
<li>dizziness</li>
<li> drowsiness</li>
<li>increased amount of saliva</li>
<li>nausea</li>
<li>shivering</li>
<li> vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Headache</li>
</ul><p>
<!-- end inhalation liquid --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sevoflurane: inhalation liquid</i></p><h3>General</h3><p>The most common adverse events were nausea, vomiting, hypotension, agitation, and cough.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (25%), vomiting (18%)</p>
<p><b>Common</b> (1% to 10%): Increased salivation</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension (11%), bradycardia</p>
<p><b>Common</b> (1% to 10%): Tachycardia, hypertension </p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, ventricular extrasystoles, supraventricular extrasystoles, complete AV block, bigeminy, inverted T wave, atrial fibrillation, atrial arrhythmia, second degree AV block, S-T depressed, extrasystoles</p>
<p><b>Frequency not reported</b>: QT prolongation, torsade de pointes</p>
<p><b>Postmarketing reports</b>: Cardiac arrest<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough increased (11%), </p>
<p><b>Common</b> (1% to 10%): Laryngospasm, airway obstruction, breath holding, apnea, respiratory disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Sputum increased, hypoxia, wheezing, bronchospasm, hyperventilation, pharyngitis, hiccup, hypoventilation, dyspnea, stridor, hypoxia, asthma</p>
<p><b>Postmarketing reports</b>: Pulmonary edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Agitation (up to 15%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Crying, nervousness, confusion, insomnia, confusional state<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Somnolence, dizziness, movement </p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, hypertonia, taste perversion</p>
<p><b>Postmarketing reports</b>: Seizures, dystonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Shivering, fever, hypothermia, headache, blood fluoride increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia, pain, fluorosis, </p>
<p><b>Rare</b> (less than 0.1%): Malignant hyperthermia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): White blood cell count abnormal</p>
<p><b>Uncommon</b> (0.1% to 1%): Hemorrhage, leukocytosis, thrombocytopenia, leukopenia</p>
<p><b>Postmarketing reports</b>: Transient elevations in white blood cell count<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function test abnormal</p>
<p><b>Uncommon</b> (0.1% to 1%): Increases in AST, increases in ALT, bilirubinemia </p>
<p><b>Postmarketing reports</b>: Hepatic dysfunction, hepatitis, jaundice, hepatic necrosis, hepatic failure, transient elevations in liver function tests<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood glucose abnormal</p>
<p><b>Uncommon</b> (0.1% to 1%): Increases in LDH, increases in alkaline phosphatase, hypophosphatemia, acidosis, hyperglycemia</p>
<p><b>Postmarketing reports</b>: Transient elevations in glucose<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increases in BUN, increases in creatinine, glycosuria, albuminuria, </p>
<p><b>Frequency not reported</b>: Mild impairment of renal concentrating ability</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Amblyopia, conjunctivitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urination impaired, urine abnormality, urinary retention, oliguria<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions, urticaria, bronchospasm, anaphylactic or anaphylactoid reaction, hypersensitivity (including contact dermatitis, rash, dyspnea, wheezing, chest discomfort, swelling face, or anaphylactic reaction)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Muscle twitching<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Ultane (sevoflurane)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Ultane (sevoflurane)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Generic Availability</li>
<li>Drug class: general anesthetics</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ultane &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Sojourn</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sevoflurane: inhalation liquid</i></p><h3>General</h3><p>The most common adverse events were nausea, vomiting, hypotension, agitation, and cough.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (25%), vomiting (18%)</p><p><b>Common</b> (1% to 10%): Increased salivation</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension (11%), bradycardia</p><p><b>Common</b> (1% to 10%): Tachycardia, hypertension </p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, ventricular extrasystoles, supraventricular extrasystoles, complete AV block, bigeminy, inverted T wave, atrial fibrillation, atrial arrhythmia, second degree AV block, S-T depressed, extrasystoles</p><p><b>Frequency not reported</b>: QT prolongation, torsade de pointes</p><p><b>Postmarketing reports</b>: Cardiac arrest<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough increased (11%), </p><p><b>Common</b> (1% to 10%): Laryngospasm, airway obstruction, breath holding, apnea, respiratory disorder</p><p><b>Uncommon</b> (0.1% to 1%): Sputum increased, hypoxia, wheezing, bronchospasm, hyperventilation, pharyngitis, hiccup, hypoventilation, dyspnea, stridor, hypoxia, asthma</p><p><b>Postmarketing reports</b>: Pulmonary edema<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Agitation (up to 15%)</p><p><b>Uncommon</b> (0.1% to 1%): Crying, nervousness, confusion, insomnia, confusional state<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Somnolence, dizziness, movement </p><p><b>Uncommon</b> (0.1% to 1%): Syncope, hypertonia, taste perversion</p><p><b>Postmarketing reports</b>: Seizures, dystonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Shivering, fever, hypothermia, headache, blood fluoride increased</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia, pain, fluorosis, </p><p><b>Rare</b> (less than 0.1%): Malignant hyperthermia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): White blood cell count abnormal</p><p><b>Uncommon</b> (0.1% to 1%): Hemorrhage, leukocytosis, thrombocytopenia, leukopenia</p><p><b>Postmarketing reports</b>: Transient elevations in white blood cell count<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function test abnormal</p><p><b>Uncommon</b> (0.1% to 1%): Increases in AST, increases in ALT, bilirubinemia </p><p><b>Postmarketing reports</b>: Hepatic dysfunction, hepatitis, jaundice, hepatic necrosis, hepatic failure, transient elevations in liver function tests<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood glucose abnormal</p><p><b>Uncommon</b> (0.1% to 1%): Increases in LDH, increases in alkaline phosphatase, hypophosphatemia, acidosis, hyperglycemia</p><p><b>Postmarketing reports</b>: Transient elevations in glucose<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increases in BUN, increases in creatinine, glycosuria, albuminuria, </p><p><b>Frequency not reported</b>: Mild impairment of renal concentrating ability</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Amblyopia, conjunctivitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urination impaired, urine abnormality, urinary retention, oliguria<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions, urticaria, bronchospasm, anaphylactic or anaphylactoid reaction, hypersensitivity (including contact dermatitis, rash, dyspnea, wheezing, chest discomfort, swelling face, or anaphylactic reaction)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Muscle twitching<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Ultane (sevoflurane)." Abbott Pharmaceutical, Abbott Park, IL. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Ultane (sevoflurane)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Generic Availability</li>
<li>Drug class: general anesthetics</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Ultane &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>